Clinical Trial

Effects of Oral Propranolol on Induction-Delivery Interval During Induction of Labour With Oxytocin

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 7, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Prolonged pregnancy could lead to perinatal and maternal complications. Oxytocin has been wildly used for induction of labour, but prolonged labour continued to occur with its attendant sequelae. Propranolol, a non-selective B-adrenergic inhibitor has been found to facilitate labour progress in some studies, by the blockade of the effects of catecholamines on the uterus though there are conflicting reports, with the only meta-analysis inconclusive due to few studies used; hence, the need to further study its role in induction of labour. The aim of this study is to assess the role of oral Propranolol in decreasing the induction-delivery with oxytocin
Trial Details
NCT Number NCT06960850
Lead Sponsor Federal Teaching Hospital Abakaliki
Conditions Propranolol, Labour Induction
Enrollment 308 participants
Start Date 2025-06-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-07